1099856

The Compounding PHY of Beverly Hills — FEI 3011764561

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 16, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Beverly Hills, CA (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
21377FDCA 501(a)(2)(A)Use of non-pharmaceutical grade components
360321 CFR 211.160(b)Scientifically sound laboratory controls